Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.13%
SPX
+0.11%
IXIC
+0.17%
FTSE
+0.69%
N225
+1.26%
AXJO
-1.06%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Consumer Discretionary
thrm
Gentherm
NASDAQ: THRM
-0.50 (-1.77%)
27.76
USD
At close at Apr 03, 20:36 UTC
Summary
News
Signals
Benchmarks
Financials

Gentherm and KNB Communications Launch ThermAffyx™ Patient Safety System for Enhanced Surgical Care

publisher logo
Cashu
24 days ago
Cashu TLDR
  • Gentherm partners with KNB Communications to launch the ThermAffyx™ Patient Safety System, enhancing surgical patient safety.
  • The ThermAffyx system reflects Gentherm's commitment to improving care quality through innovative healthcare technology.
  • Gentherm's collaboration focuses on effective communication about the system as it awaits FDA approval anticipated in May.
thrm Logo
THRM
Gentherm
-1.77%

Gentherm Partners with KNB Communications to Launch Innovative Patient Safety System

In a significant move within the healthcare technology sector, Gentherm, a prominent leader in thermal management and pneumatic comfort technologies, announces its partnership with KNB Communications to support the launch of the ThermAffyx™ Patient Safety System. This innovative device is designed to address the crucial challenges of patient warming and securement during surgical procedures, which are key factors in improving overall patient safety. With the support from KNB Communications, Gentherm aims to not only promote this cutting-edge solution but also reinforce its commitment to enhancing the quality of care in surgical settings.

Steve Fletcher, Gentherm's Senior Vice President and General Manager, articulates the clinical necessity behind the ThermAffyx system, noting that it originated from surgeons' recognition of Gentherm’s expertise in elevating patient safety standards. This collaboration is pivotal as it combines Gentherm's engineering innovation with KNB's marketing acumen, effectively translating complex medical advancements into compelling narratives for healthcare professionals and stakeholders. The strategic alliance is particularly relevant at a time when patient outcomes and safety remain top priorities in the medical field.

The momentum for the ThermAffyx Patient Safety System is amplified by Gentherm’s recent submission of a 510(k) Class II premarket notification to the FDA. Approval for this innovative device is anticipated in May, positioning Gentherm at the forefront of advancements in surgical technology. Chintan Shah, President of KNB Communications, highlights the agency's excitement about the partnership, especially its focus on crafting communications that resonate with clinicians, investors, and patients alike. This initiative not only underscores Gentherm's proactive approach to healthcare innovation but also reflects a broader commitment to improving surgical outcomes through strategic partnerships.

In addition to its healthcare initiatives, Gentherm is recognized for its pioneering automotive products, particularly its Climate Control Seats (CCS®). This dual focus on automotive and healthcare technologies demonstrates the company's versatility and innovative spirit, reinforcing its status as a leader across multiple sectors. By enhancing awareness of its market solutions through strategic communication, Gentherm positions itself to drive forward the future of healthcare technologies while fulfilling its mission to improve patient safety.

The collaboration with KNB Communications signals a progressive step for Gentherm as it continues its journey to revolutionize the medical device landscape. As the anticipation for FDA clearance builds, the company seeks to highlight the significance of the ThermAffyx system, aiming to become a beacon of safety and efficiency in surgical environments. This partnership not only illustrates a commitment to patient-centric solutions but also showcases Gentherm’s aspiration to lead the conversation around critical advancements in healthcare.

The content provided here is for informational purposes only and should not be considered financial or investment advice. Investing in stocks carries risks, including potential loss of principal. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We are not responsible for any losses or damages resulting from your use of this information.

More News

Feature in Progress
This section is under development. Check back soon for updates!
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.